Bibliometric analysis of rheumatic immune related adverse events associated with immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibitors (ICIs) has emerged as a popular cancer treatment approach. However, non-specific activation of T cells by ICIs can lead to immune-related adverse events (irAEs), including specific rheumatic manifestations. The study aimed to explore the current trend of ICIs...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Li, Ma, Gang, Chen, Kai, Zhou, Qiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587544/
https://www.ncbi.nlm.nih.gov/pubmed/37869006
http://dx.doi.org/10.3389/fimmu.2023.1242336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587544/
https://www.ncbi.nlm.nih.gov/pubmed/37869006
http://dx.doi.org/10.3389/fimmu.2023.1242336

Ejemplares similares